Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau

Vaccine

Volumn 24, Issue 29-30, 2006, Pages 5718-5725

  Aaby, Peter ^a,b   Gustafson, Per ^a   Roth, Adam ^a,b   Rodrigues, Amabelia ^a   Fernandes, Manuel ^a   Sodemann, Morten ^a,b   Holmgren, Birgitta ^a,b   Benn, Christine Stabell ^a,b   Garly, May Lill ^a,b   Lisse, Ida Maria ^a,b   Jensen, Henrik ^a,b  

^a Projecto de Saúde de Bandim ^*  (Denmark)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

Author keywords

Adult mortality; Beneficial effects of vaccination; HIV 2; Non targeted effects of vaccination; Smallpox vaccination; Vaccinia

Indexed keywords

BCG VACCINE; VACCINIA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; ETHNOLOGY; FEMALE; GUINEA-BISSAU; HEALTH SURVEY; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION; MALE; MORTALITY; OUTCOME ASSESSMENT; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SCAR; SCHOOL; SEX RATIO; SOCIOECONOMICS; SURVIVAL; TIME SERIES ANALYSIS; URBAN AREA; VACCINATION; VACCINIA; VACCINIA SCAR;

ADULT; AGED; BCG VACCINE; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HIV-2; HUMANS; MALE; MIDDLE AGED; SMALLPOX VACCINE; SURVIVAL ANALYSIS; VACCINATION; VACCINIA VIRUS;

EID: 33745438144     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.045     Document Type: Article

References (38)

1. Mercer A. Disease mortality and population in transition (1990), Leicester University Press, Leicester
2. Henderson D.A., and Moss B. Smallpox and vaccinia. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. third ed. (1999), W.B. Saunders Company, Philadelphia 74-97
3. Aaby P., Samb B., Simondon F., Coll Seck A.M., Knudsen K., and Whittle H. Non-specific beneficial effect of measles immunization: analysis of mortality studies from developing countries. BMJ 311 (1995) 481-485
4. Kristensen I., Aaby P., and Jensen H. Routine vaccinations and child survival: follow-up study in Guinea-Bissau. BMJ 321 (2000) 1435-1438
5. Velema J.P., Alihonou E.J., Gandaho T., and Hounye F.H. Childhood mortality among users and non-users of primary health care in a rural West African community. Int J Epidemiol 20 (1991) 474-479
6. Aaby P., Samb B., Simondon F., Knudsen K., Coll Seck A.M., Bennett J., et al. Divergent mortality for male and female recipients of low-titre and high-titre measles vaccines in rural Senegal. Am J Epidemiol 138 (1993) 746-755
7. Ashorn P., Maleta K., Espo M., and Kulmala T. Male-biased mortality among 1-2 years old children in rural Malawi. Arch Dis Child 87 (2002) 386-387
8. Garly M.L., Martins C.L., Balé C., Baldé M.A., Hedegaard K.L., Gustafson P., et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: a non-specific beneficial effect of BCG?. Vaccine 21 (2003) 2782-2790
9. Knudsen K.M., Aaby P., Whittle H., Rowe M., Samb B., Simondon F., et al. Child mortality following standard, medium and high titre measles vaccination in West Africa. Int J Epidemiol 25 (1996) 665-673
10. Aaby P., Garly M.L., Balé C., Martins C., Lisse I., and Jensen H. Routine vaccinations and child survival in war situation with high mortality: effect of gender. Vaccine 21 (2002) 15-20
11. Aaby P., Jensen H., Samb B., Cisse B., Sodeman M., Jakobsen M., et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: a re-analysis of the West African studies. Lancet 361 (2003) 2183-2188
12. Ennis F.A., Cruz J., Demkowicz Jr. W.E., Rothman A.L., and McClain D.J. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma producing cells after smallpox vaccination. JID 185 (2002) 1657-1659
13. Frey S.E., Newman F.K., Cruz J., Shelton W.B., Tennant J.M., Polach T., et al. Dose-related effects of smallpox vaccine. NEJM 346 (2002) 1275-1280
14. Aaby P., Gomes J., Fernandes M., Djana Q., Lisse I., and Jensen H. Nutritional status and mortality of refugee and resident children in a non-camp setting during conflict: follow up study in Guinea-Bissau. BMJ 319 (1999) 878-881
15. McCullagh P., and Nelder J.A. Generalized linear models. second ed. (1989), Chapman & Hall, London
16. Cox D.R., and Oakes D. Analysis of survival data (1984), Chapman & Hall, London
17. Holmgren B., da Silva Z., Larsen O., Vastrup P., Andersson S., and Aaby P. Dual infections of HIV-1, HIV-2, and HTLV-I are more common in older women than men in Guinea-Bissau. AIDS 17 (2003) 241-253
18. Fine P.E.M., Ponninghaus J.M., and Maine N. The distribution and implications of BCG scars in northern Malawi. Bull WHO 67 (1989) 35-42
19. Poulsen A.G., Aaby P., Larsen O., Jensen H., Naucler A., Lisse I.M., et al. Nine-year HIV-2 associated mortality in an urban community in Bissau, West Africa. Lancet 349 (1997) 911-914
20. Larsen O., da Silva Z., Sandström A., Andersen P.K., Andersson S., Poulsen A.G., et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS 12 (1998) 1707-1714
21. Aaby P., Bhuyia A., Nahar L., Knudsen K., Francisco A., and Strong M. The survival benefit of measles immunisation may not be explained entirely by the prevention of measles disease. Int J Epidemiol 32 (2003) 106-115
22. Aaby P., Samb B., Simondon F., Cisse B., Jensen H., Lisse I.M., et al. Low mortality after mild measles infection compared to uninfected children in rural west Africa. Vaccine 21 (2002) 120-126
23. Gilat T., Hacohen D., Lilos P., and Langman M.J. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scan J Gastroenterol 22 (1987) 1009-1024
24. Kurtzke J.F., Hyllested K., Arbuckle J.D., Bronnum-Hansen H., Wallin M.T., Heltberg A., et al. Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurol Scand 96 (1997) 149-157
25. Grufferman S., Wang H.H., DeLong E.R., Kimm S.Y., Delzell E.S., and Falletta J.M. Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst 68 (1982) 107-113
26. Pfahlberg A., Køhmel K.F., Grange J.M., et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. J Invest Dermatol 119 (2002) 570-575
27. Kolmel K.F., Grange J.M., Krone B., Mastrangelo G., Rossi C.R., Henz B.M., et al. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. A European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer 41 1 (2005) 118-125
28. Bager P., Westergaard T., Rostgaard K., Nielsen N.M., Melbye M., and Aaby P. Smallpox vaccination and risk of atopy and asthma. J Allergy Clin Immun 111 (2003) 1127-1131
29. Blom L., Nyström L., and Dahlquist G. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 34 (1991) 176-181
30. Classen J., and Classen D.C. Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity 31 (1999) 43-45
31. Aaby P., Bukh J., Lisse I.M., and Smits A.J. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 8 (1984) 13-21
32. Aaby P., Lisse I., Mølbak K., Knudsen K., and Whittle H. No persistent T lymphocyte immunosuppression or increased mortality after measles infection: a community study from Guinea-Bissau. Pediatr Inf Dis J 15 (1996) 39-44
33. Aaby P., Samb B., Andersen M., and Simondon F. No long-term excess mortality after measles infection: a community study from Senegal. Am J Epidemiol 143 (1996) 1035-1041
34. Moore Z.S., Seward J.F., and Lane J.M. Smallpox. Lancet 367 (2006) 425-435
35. Mack T. A different view of smallpox and vaccination. N Engl J Med (2003) 349
36. Bozzette S.A., Boer R., Bhatnagar V., Brower J.L., Keeler E.B., Morton S.C., et al. A model for a smallpox-vaccination policy. N Engl J Med (2003) 349
37. Bicknell W., and James K. The new cell culture smallpox vaccine should be offered to the general population. Rev Med Virol 13 (2003) 5-15
38. Mortimer P.P. The new cell culture smallpox vaccine should not be offered to the general population. Rev Med Virol 13 (2003) 17-20